EUVIMEDEUVIMED entdecken
Crossref

Inflammation-triggering Engineered Macrophages (MacTriggers) Are Promising Cell-based Therapeutic Avenues for Chemoresistant Solid Tumors

Teruki Nii, Toma Yoshimi, Kenta Tanito, Shoichi Hijii, Haruka Takata, Akihiro Kishimura, Takeshi Mori, Tatsuhiro Ishida, Yoshiki Katayama

Anticancer Research · 2025

DOI: 10.21873/anticanres.17525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Teruki Nii und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Systems Life Sciences, Kyushu University, Fukuoka, Japan; nii.teruki.204@m.kyushu-u.ac.jp. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Macrophages, Inflammation, Colonic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmMacrophagesInflammationColonic NeoplasmsAnimalsMiceDoxorubicinCell Line, TumorMice, Inbred BALB CTumor Necrosis Factor-alphaHumansTumor MicroenvironmentFemale

Stichwörter der Autor:innen

Chemoresistant tumorscell medicineinflammation

Substanzen

DoxorubicinTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Graduate School of Systems Life Sciences, Kyushu University, Fukuoka, Japan; nii.teruki.204@m.kyushu-u.ac.jp.
  • Department of Applied Chemistry, Faculty of Engineering, Kyushu University, Fukuoka, Japan.
  • Graduate School of Systems Life Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Center for Future Chemistry, Kyushu University, Fukuoka, Japan.
  • Center for Molecular Systems, Kyushu University, Fukuoka, Japan.

Zitieren

APA

Nii, T., Yoshimi, T., Tanito, K., Hijii, S., Takata, H., Kishimura, A., Mori, T., Ishida, T., & Katayama, Y. (2025). Inflammation-triggering Engineered Macrophages (MacTriggers) Are Promising Cell-based Therapeutic Avenues for Chemoresistant Solid Tumors. Anticancer Research. https://doi.org/10.21873/anticanres.17525

Vancouver

Nii T, Yoshimi T, Tanito K, Hijii S, Takata H, Kishimura A, et al. Inflammation-triggering Engineered Macrophages (MacTriggers) Are Promising Cell-based Therapeutic Avenues for Chemoresistant Solid Tumors. Anticancer Research. 2025. doi:10.21873/anticanres.17525

BibTeX
@article{Nii2025,
  author = {Nii, Teruki and Yoshimi, Toma and Tanito, Kenta and Hijii, Shoichi and Takata, Haruka and Kishimura, Akihiro and Mori, Takeshi and Ishida, Tatsuhiro and Katayama, Yoshiki},
  title = {Inflammation-triggering Engineered Macrophages (MacTriggers) Are Promising Cell-based Therapeutic Avenues for Chemoresistant Solid Tumors},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17525}
}
Kostenlos starten →